GCI Methodology - Biotechnology
Classification Guide for Sectors, Categories, Subcategories, Types, Subtypes, and Applications
- GCI Sectors
- Artificial Intelligence (AI) and Quantum Computing
- Biotechnology and Biomanufacturing
- Critical Minerals and Advanced Materials
- Cybersecurity, Space, and Defense Technology
- Energy Security
- Food Security and Agricultural Technology
- Manufacturing Advancements and Supply Chain Resilience
- Semiconductors and Microelectronics
- GCI Sectors
- Artificial Intelligence (AI) and Quantum Computing
- Biotechnology and Biomanufacturing
- Critical Minerals and Advanced Materials
- Cybersecurity, Space, and Defense Technology
- Energy Security
- Food Security and Agricultural Technology
- Manufacturing Advancements and Supply Chain Resilience
- Semiconductors and Microelectronics
3. CATEGORY: BIOTECHNOLOGY
Biotechnology encompasses the use of biological systems, organisms, or derivatives for creating products and solutions in fields like healthcare, agriculture, food, and environmental sustainability.
3.2. Subcategory: Agricultural Biotechnology
3.2.4. Type: Agricultural Microbials: The use of beneficial microorganisms (e.g., rhizobacteria) to improve soil health, plant growth, or pest control
3.2.2. Type: Biopesticides: Biological solutions for pest control, often derived from microorganisms, plants, or natural substances
3.2.3. Type: Biostimulants: Products that promote plant growth and productivity by enhancing physiological processes, such as microbial inoculants or seaweed extracts
3.2.1. Type: Genetically Modified Organisms (GMOs): Crops or animals altered to enhance traits like disease resistance, yield, or nutritional content
- 3.2.1.2. Subtype: Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) and Gene Editing: Precision gene editing tools to modify plant and animal genomes for agricultural purposes
- 3.2.1.1. Subtype: GM Crops: Genetically modified plants such as Bt corn, herbicide-resistant soybeans, and drought-tolerant rice
3.2.5. Type: Precision Agriculture: Use of advanced technology (e.g., sensors, AI, drones) for more efficient and sustainable farming practices
3.4. Subcategory: Environmental Biotechnology
- 3.4.2. Type: Bioremediation and Pollution Control: The use of organisms to clean up contaminants, such as oil spills, plastic waste, or hazardous chemicals
- 3.4.3. Type: Carbon Sequestration: Techniques for capturing and storing atmospheric carbon dioxide through biological processes, such as in algae or forest restoration
- 3.4.4. Type: Environmental Sensors: Development of biosensors for detecting environmental pollutants, such as heavy metals
- 3.4.1. Type: Wastewater Treatment: Using biological processes (e.g., bacteria) to treat sewage and industrial wastewater, turning waste into reusable water or other products
3.3. Subcategory: Industrial Biotechnology (White Biotechnology)
- 3.3.2. Type: Biochemical Production: Using microorganisms or enzymes to produce industrial chemicals such as bioplastics, solvents, and detergents
- 3.3.2.1. Subtype: Bio-based Chemicals: Production of chemicals from renewable biological sources instead of petroleum-based raw materials.
- 3.3.1. Type: Biofuels: The production of energy from biological sources, including ethanol, biodiesel, and next-generation biofuels (e.g., algae-based biofuels)
- 3.3.4. Type: Bioinformatics: The convergence of biological data and computational science; which uses these methods to analyze and interpret large biological datasets
- 3.3.3. Type: Biopolymers and Bioplastics: Production of biodegradable plastics and polymers from biological feedstocks like corn or sugarcane (e.g., Polylactic acid (PLA), polyhydroxyalkanoates (PHA))
3.5. Subcategory: Food and Nutrition Biotechnology
- 3.5.4. Type: Alternative Proteins: Development of plant-based and lab-grown meat products to reduce environmental impacts of animal agriculture
- 3.5.2. Type: Fermentation: Biotechnology for producing food and beverages, such as yogurt and cheese, using microorganisms
- 3.5.1. Type: Food Production: Use of biotechnology to enhance food quality, shelf life, and nutritional value
- 3.5.5. Type: Food Safety: Technology such as biosensors and genetic techniques for detecting foodborne pathogens or contaminants in food
- 3.5.3. Type: Functional Foods: Foods that provide health benefits beyond basic nutrition, such as probiotics, antioxidants, and biofortified foods
3.1. Subcategory: Medical Biotechnology
3.1.2. Type: Diagnostic Biotechnology: Tools and methods for early detection and diagnosis of diseases
- 3.1.2.3. Subtype: Immunoassays: Tests based on antibody-antigen reactions used to detect diseases or biomarkers
- 3.1.2.1. Subtype: Molecular Diagnostics: Technology such as Polymerase Chain Reaction (PCR) and next-generation sequencing for detecting pathogens, genetic diseases, or cancers
- 3.1.2.2. Subtype: Point-of-Care Diagnostics: Portable diagnostic devices that provide rapid results outside traditional laboratory settings
3.1.4. Type: Metabolic Engineering: Alters metabolic pathways with genetic techniques in order to create valuable products, cost-effectively
- 3.1.4.2. Subtype: Development of Nutritionally Enhanced Products: Technology supporting development of crops or renewable fuels
- 3.1.4.1. Subtype: Industrial-scale Production: Technology supporting the development of antibiotics, enzymes, and bio-based chemicals
3.1.1. Type: Pharmaceuticals & Biopharmaceuticals: Development and production of therapeutic drugs and vaccines derived from biological sources
- 3.1.1.13. Subtype: Advanced Drug Delivery Systems: Innovative technology and formulations that enhance the delivery, bioavailability, and efficacy of pharmaceutical drugs. These systems focus on targeted distribution, controlling drug release rates, and minimizing side effects
- 3.1.1.12. Subtype: Biomarker Discovery and Validation: A systematic process of identifying, developing, and confirming molecular indicators that can be used to detect biological processes, disease states, or responses to therapeutic interventions
- 3.1.1.1. Subtype: Biomedical Enhancements: Taking otherwise healthy service personnel (soldiers, marines, pilots, etc.) and pushing their biological, physiological, and cognitive capacities beyond their individual statistical or baseline norm e.g. developing enhanced warfighters
- 3.1.1.4. Subtype: Cell-based Therapy and Delivery Systems: Using living cells to treat diseases, such as stem cell therapies for regenerative medicine or bacteriophages for protein or DNA delivery
- 3.1.1.9. Subtype: Combination Products: Therapeutic or diagnostic products that combine two or more regulated components: drugs, medical devices, and/or biological products
- 3.1.1.10. Subtype: Digital Therapeutics: Evidence-based software interventions that prevent, manage, or treat medical disorders or diseases
- 3.1.1.6. Subtype: Drug Discovery: Utilization of machine learning and biodesign tools (BDTs) to aid in drug discovery from molecule libraries
- 3.1.1.7. Subtype: Extended Protein-based Therapeutics: Modified versions of protein drugs designed to prolong their therapeutic effects and improve their pharmacokinetic properties
- 3.1.1.8. Subtype: Extracellular Vesicle Therapeutics: An emerging class of treatments that utilize naturally occurring or bioengineered nanoparticles secreted by cells to deliver therapeutic agents or elicit beneficial effects in recipient cells
- 3.1.1.3. Subtype: Gene Therapy and Synthesis: Introducing, removing, creating, or altering genetic material within cells to treat or prevent disease
- 3.1.1.2. Subtype: Monoclonal Antibodies: Engineered antibodies for targeted treatment of diseases like cancer and autoimmune disorders
- 3.1.1.11. Subtype: Personalized Medicine Approaches: Tailor medical treatments and preventive strategies to individual patients based on their unique genetic, environmental, and lifestyle factors
- 3.1.1.5. Subtype: RNA-based Therapeutics: Including messenger RNA (mRNA) vaccines (e.g., COVID-19 vaccines) and other RNA therapeutics
3.1.5. Type: Regenerative Medicine: A field of medicine that focuses on repairing, replacing, or regenerating damaged tissues and organs using techniques such as stem cell therapy, tissue engineering, and gene editing
- 3.1.5.5. Subtype: Blood Alternative: Shelf-stable resuscitation fluid via bio-artificial and synthetic components to replace volume and oxygen, while stopping a bleed
- 3.1.5.3. Subtype: Gene Editing for Regenerative Medicine: Using technology like Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) to correct genetic disorders at the cellular level
- 3.1.5.4. Subtype: Organ-on-a-Chip: Microfluidic devices that simulate human organs for drug testing, disease modeling, and personalized medicine
- 3.1.5.1. Subtype: Stem Cell Therapy: Using stem cells to regenerate damaged tissues or organs, with applications in treating neurological, cardiovascular, and musculoskeletal disorders
- 3.1.5.2. Subtype: Tissue Engineering: Growing functional tissues or organs from cells in the lab for transplantation or research
3.1.3. Type: Synthetic Biology: Combines biology and engineering to create new biological parts, devices, and systems, or to improve existing ones
- 3.1.3.2. Subtype: Agriculture: Creating products such as pest-resistant crops
- 3.1.3.1. Subtype: Healthcare: Innovations in drug production
- 3.1.3.3. Subtype: Manufacturing: Developing biofuels and bioplastics
3.6. Subcategory: Veterinary Biotechnology
- 3.6.1. Type: Animal Health: Development of vaccines, diagnostics, and therapeutics for diseases affecting livestock, pets, and wildlife
- 3.6.4. Type: Biopharmaceuticals for Animals: Development of biological drugs or therapeutics for animal diseases, similar to biopharmaceuticals for humans
- 3.6.2. Type: Genetic Improvement of Livestock: Genetic engineering or selective breeding to improve traits such as disease resistance, productivity, and quality of meat, milk, or wool
- 3.6.3. Type: Reproductive Biotechnology: Techniques such as artificial insemination, embryo transfer, and cloning used to enhance breeding in animals